Administration of cyclosporine a in pregnant rats - the effect on blood pressure and on the glomerular number in their offspring

Kidney and Blood Pressure Research

Volumn 40, Issue 4, 2015, Pages 413-423

  Slabiak Blaz, Natalia ^a   Adamczak, Marcin ^a   Gut, Nadezda ^b   Grajoszek, Aniela ^a   Nyengaard, Jens R ^c   Ritz, Eberhard ^d   Wiecek, Andrzej ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Memmingen Hospital   (Germany)

^c AARHUS UNIVERSITY   (Denmark)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Chronic kidney disease; Cyclosporine A; Glomerular number; Hypertension; Kidney development; Pregnant rats

Indexed keywords

CREATININE; CYCLOSPORIN A; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ALBUMINURIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG EXPOSURE; FEMALE; GLOMERULUS; KIDNEY DEVELOPMENT; KIDNEY FUNCTION; KIDNEY MASS; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROGENY; RAT; SYSTOLIC BLOOD PRESSURE; ADULT; ANIMAL; BIRTH WEIGHT; DRUG EFFECTS; EMBRYOLOGY; GROWTH, DEVELOPMENT AND AGING; HUMAN; KIDNEY FUNCTION TEST; LITTER SIZE; METABOLISM; ORGAN SIZE; PREGNANCY; PREGNANCY OUTCOME; SPRAGUE DAWLEY RAT;

ADULT; ALBUMINURIA; ANIMALS; BIRTH WEIGHT; BLOOD PRESSURE; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; KIDNEY GLOMERULUS; LITTER SIZE; ORGAN SIZE; PREGNANCY; PREGNANCY OUTCOME; RATS, SPRAGUE-DAWLEY;

EID: 84939495832     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000368515     Document Type: Article

References (45)

1. Barker DJ: The developmental origins of adult disease. J Am Coll Nutr 2004;23:588S-595S.
2. Brenner BM, Chertow GM: Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 1994;23:171-175.
3. Brenner BM, Garcia DL, Anderson S: Glomeruli and blood pressure: Less of one, more the other? Am J Hypertens 1988;1:335-347.
4. Brenner BM, Lawler EV, Mackenzie HS: The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 1996;49:1774-1777.
5. Brenner BM, Mackenzie HS: Nephron mass as a risk factor for progression of renal disease. Kidney Int 1997;63:S124-S127.
6. Woods LL, Ingelfinger JR, Nyengaard JR, Rasch R: Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res 2001;49:460-467.
7. Celsi G, Kistner A, Aizman R, Eklöf AC, Ceccatelli S, de Santiago A, Jacobson SH: Prenatal dexamethasone causes oligonephronia, sodium retention, and higher blood pressure in the offspring. Pediatr Res 1998;44:317-322.
8. Lelivre-Pégorier M, Vilar J, Ferrier ML, Moreau E, Freund N, Gilbert T, Merlet-Bénichou C: Mild vitamin A deficiency leads to inborn nephron deficit in the rat. Kidney Int 1998;54:1455-1462.
9. Gray SP, Denton KM, Cullen-McEwen L, Bertram JF, Moritz KM: Prenatal exposure to alcohol reduces nephron number and raises blood pressure in progeny. J Am Soc Nephrol 2010;21:1891-1902.
10. Keller G, Zimmer G, Mall G, Ritz E, Amann K: Nephron number in patients with primary hypertension. N Engl J Med 2003;348:101-108.
11. Bar Oz B, Hackman R, Einarson T, Koren G: Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 2001;71:1051-1055.
12. Venkataramanan R, Koneru B, Wang CCP, Burckart GJ, Caritis SN, Starzl TE: Cyclosporine and its metabolites in mother and baby. Transplantation 1988;46:468-469.
13. Gilbert T, Gaonach S, Moreau E, Merlet-Bénichou C: Effect of cyclosporin A (CsA) on rat metanephros differentiation in vitro. J Am Soc Nephrol 1994;5:623A.
14. Cochat P, Decramer S, Robert-Gnansia E, Dubourg L, Audra P: Renal outcome of children exposed to cyclosporine in utero. Transplant Proc 2004;36:208S-210S.
15. Giudice PL, Dubourg L, Hadj-Assa A, Sad MH, Claris O, Audra P, Martin X, Cochat P: Renal function of children exposed to cyclosporine in utero. Nephrol Dial Transplant 2000;15:1575-1579.
16. Shaheen FAM, Alsulaiman MH, Alkhader AA: Long-term nephrotoxicity after exposure to ciclosporine in utero. Transplantation 1993;56:224-225.
17. Nyengaard JR: Stereologic methods and their application in kidney research. J Am Soc Nephrol 1999;10:1100-1123.
18. Slabiak-Blaz N, Adamczak M, Wystrychowski A, Ritz E, Więcek A: Pharmacokinetics of cyclosporine A, tacrolimus and sirolimus given subcutaneously in normal rats. Nefrol Dial Pol 2013;17:53-55.
19. Schreuder MF, Nyengaard JR, Fodor M, van Wijk JA, Delemarre-van de Waal HA: Glomerular number and function are influenced by spontaneous and induced low birth weight in rats. J Am Soc Nephrol 2005;16:2913-2919.
20. Mc Kay DB, Josephson MA: Pregnancy after kidney transplantation. Clin J Am Soc Nephrol 2008;3:S117-S125.
21. Zachariah MS, Tornatore KM, Venuto RC: Kidney transplantation and pregnancy. Curr Opin Organ Transplant 2009;14:386-391.
22. Bertram JF: Counting in the kidney. Kidney Int 2001;59:792-796.
23. Tendron A, Decramer S, Justrabo E, Gouyon JB, Semama DS, Gilbert T: Cyclosporine A administration during pregnancy induces a permanent nephron deficit in young rabbits. J Am Soc Nephrol 2003;14:3188-3196.
24. Rookmaaker MB, Joles JA: The nephron number counts - from womb to tomb. Nephrol Dial Transplant 2013;26:1325-1328.
25. Menendez-Castro C, Hilgers KF, Amann K, Daniel C, Cordasic N, Wachtveitl R, Fahlbusch F, Plank C, Dötsch J, Rascher W, Hartner A: Intrauterine growth restriction leads to a dysregulation of Wilms' tumour supressor gene 1 (WT1) and to early podocyte alterations. Nephrol Dial Transplant 2013;28:1407-1417.
26. Koleganova N, Piecha G, Ritz E, Becker LE, Mller A, Weckbach M, Nyengaard JR, Schirmacher P, Gross-Weissmann ML: Both high and low maternal salt intake in pregnancy alter kidney development in the offspring. Am J Physiol Renal Physiol 2011;301:F344-F354.
27. Hallan S, Euser AM, Irgens LM, Finken MJJ, Holmen J, Dekker FW: Effect of intrauterine growth restriction on kidney function at young adult age: The Nord Trndelag Health (HUNT 2) Study. Am J Kidney Dis 2008;51:10-20.
28. Ozaki T, Nishina H, Hanson MA, Poston L: Dietary restriction in pregnant rats causes gender related hypertension and vascular dysfunction in offspring. J Physiol 2001;530:141-152.
29. Woods LL, Ingelfinger JR, Rasch R: Modest maternal protein restriction fails to program adult hypertension in female rats. Am J Physiol Regul Integr Comp Physiol 2005;289:R1131-1136.
30. Hoy WE, Hughson MD, Singh GR, Douglas-Denton R, Bertram JF: Reduced nephron number and glomerulomegaly in Australian aborigines: a group at high risk for renal disease and hypertension. Kidney Int 2006;70:104-110.
31. Hughson MD, Douglas-Denton R, Bertram JF, Hoy WE: Hypertension, glomerular number, and birth weight in African Americans and white subjects in the southeastern United States. Kidney Int 2006;69:671-678.
32. Zarzecki M, Adamczak M, Wystrychowski A, Gross ML, Ritz E, Więcek A: Exposure of pregnant rats to cigarette-smoke condensate causes glomerular abnormalities in offspring. Kidney Blood Press Res 2012;36:162-171.
33. Tendron-Franzin A, Gouyon JB, Guignard JP, Decramer S, Justrabo E, Gilbert T, Semama DS: Longterm effects of in utero exposure to cyclosporine A on renal function in the rabbit. J Am Soc Nephrol 2004;15:2687-2693.
34. Gilbert JS, Lang AL, Grant AR, Nijland MJ: Maternal nutrient restriction in sheep: hypertension and decreased nephron number in offspring at 9 months of age. J Physiol 2005;565:137-147.
35. Hoppe CC, Evans RG, Moritz KM, Cullen-McEwen LA, Fitzgerald SM, Dowling J, Bertram JF: Combined prenatal and postnatal protein restriction influences adult kidney structure, function, and arterial pressure. Am J Physiol Regul Integr Comp Physiol 2007;292:R462-R469.
36. Reichetzeder C, Chen H, Föller M, Slowinski T, Li J, Chen YP, Lang F, Hocher B: Maternal vitamin D deficiency and fetal programming-lessons learned from humans and mice. Kidney Blood Press Res 2014;39:315-329.
37. Zhang S, Regnault TR, Barker PL, Botting KJ, McMillen IC, McMillan CM, Roberts CT, Morrison JL: Placental adaptations in growth restriction. Nutrients 2015;7:360-389.
38. Jansson T, Powell TL: Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond) 2007;113:1-13.
39. Li J, Chen YP, Dong YP, Yu CH, Lu YP, Xiao XM, Hocher B: The impact of umbilical blood flow regulation on fetal development differs in diabetic and non-diabetic pregnancy. Kidney Blood Press Res 2014;39:369-377.
40. Seckl JR, Holmes MC: Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology. Nat Clin Pract Endocrinol Metab 2007;3:479-488.
41. Gray SP, Kenna K, Bertram JF, Hoy WE, Yan EB, Bocking AD, Brien JF, Walker DW, Harding R, Moritz KM: Repeated ethanol exposure during late gestation decreases nephron endowment in fetal sheep. Am J Physiol Regul Integr Comp Physiol 2008;295:R568-R574.
42. Schreuder M, Delemarre-van de Waal HA, van Wijk A: Consequences of intrauterine growth restriction for the kidney. Kidney Blood Press Res 2006;29:108-125.
43. Miao Z, Chen M, Wu H, Ding H, Shi Z: Comparative proteomic profile of the human placenta in normal and fetal growth restriction subjects. Cell Physiol Biochem 2014;34:1701-1710.
44. Alwasel SH, Kaleem I, Sahajpal V, Ashton N: Maternal protein restriction reduces angiotensin II AT1 and AT2 receptor expression in the fetal rat kidney. Kidney Blood Press Res 2010;33:251-259.
45. Langley-Evans SC: Developmental programming of health and disease. Proceed Nutr Soc 2006;65:97-105.